Forta Research · Healthcare & Life Sciences

Care won’t be replaced. The admin around it will change.
Careers don’t have to end.

In healthcare, AI exposure concentrates in administration, coordination and documentation rather than front-line care. The direction of travel is augmentation — and a large administrative layer that needs managed transition.

Sector: Healthcare & Life Sciences (CQC · MHRA) · Illustrative · Methodology v1.3 · 15 July 2026

The issue

Exposure sits in the administrative layer around care, not in care itself.

Clinical roles are constrained by physical presence, regulation and trust, and are being augmented rather than displaced. The workforce question is the substantial admin, coordination and documentation layer — and life-sciences functions in regulatory affairs and data.

Illustrative exposure view

relative automation pressure by role cluster — not a measurement, orientation only

Clinical documentation & adminHigh
Appointment & pathway coordinationHigh
Medical coding & billingElevated
Life-sciences regulatory & docsElevated
Back-office & procurementElevated
Direct clinical careLower

NHS England has announced AI tools for around 500,000 staff to free clinical time; sourced figures appear in the sector white paper. This view is illustrative.

How we help · The Forta Method

Five stages. One accountability structure.

01 · AUDIT

Board-ready diagnostic

Task-level exposure mapped across the workforce, tiered by pressure and confidence.

02 · VALIDATE

Costed transition plan

Cohorts confirmed with data; eligible funding routes identified and validated; a sequenced plan.

03 · RETRAIN

Funded, AI-native

Reskilling delivered through routes the employer is eligible for, at AI-native cost.

04 · REDEPLOY

Internal first

People moved into higher-value internal roles the organisation is short of.

05 · EVIDENCE

Re-baselined annually

Every material decision documented and traceable; re-baselined as the work moves.

The real cost

Costs of handling it badly

  • Severance & settlement exposure
  • Employment-tribunal & consultation risk
  • Lost institutional & operational knowledge
  • Re-hire cost when the capability gap reopens
  • ESG, conduct & reputation exposure

Ranges, sourced and dated — never a single settled percentage.

Internal destinations first

  • Patient-facing coordination & care navigation
  • Complex casework & vulnerable-patient support
  • Data quality & AI-assurance roles
  • Clinical-admin supervision

External placement is a secondary story — cost avoidance and ESG, never the headline.

Evidence boundary

Readiness, not compliance. This supports workforce-transition readiness. It is not legal advice, and not compliance with worker-management AI rules.

Funding is identified, not guaranteed. Forta validates eligible routes; it never implies public funding is automatic.

No outcome claims yet. Forta is pre-reference. This material is illustrative — no client results are represented.

Sourced figures live in the Healthcare & Life Sciences white paper with source, date and scope on every number.

Free clinical time — without losing the people around it.

Forta is opening a small founding cohort of regulated UK employers. Founding terms, board-ready output, and accountability from diagnosis to outcome.

White paper · Published

Augmenting the Workforce